|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
|
|---|---|---|---|
| Assets | |||
| Cash and balances at central banks | |||
| Items in the course of collection from other banks | |||
| Trading assets | |||
| Financial assets designated and otherwise mandatorily measured at fair value through profit or loss | |||
| Derivatives | |||
| Loans and advances to banks | |||
| Loans and advances to customers | |||
| Reverse repurchase agreements – non-trading | |||
| Financial investments | |||
| Assets held for sale | |||
| Prepayments, accrued income and other assets | |||
| Current tax assets | |||
| Interests in associates and joint ventures | |||
| Goodwill and intangible assets | |||
| Deferred tax assets | |||
| Total assets | |||
| Liabilities and equity | |||
| Liabilities | |||
| Deposits by banks | |||
| Customer accounts | |||
| Repurchase agreements – non-trading | |||
| Items in the course of transmission to other banks | |||
| Trading liabilities | |||
| Financial liabilities designated at fair value | |||
| Derivatives | |||
| Debt securities in issue | |||
| Liabilities of disposal groups held for sale | |||
| Accruals, deferred income and other liabilities | |||
| Current tax liabilities | |||
| Liabilities under insurance contracts | |||
| Insurance contract liabilities | |||
| Provisions | |||
| Deferred tax liabilities | |||
| Subordinated liabilities | |||
| Total liabilities | |||
| Equity | |||
| Total shareholders’ equity | |||
| – called up share capital | |||
| – share premium account | |||
| – other equity instruments | |||
| – retained earnings | |||
| – other reserves | |||
| Non-controlling interests | |||
| Total equity | |||
| Total liabilities and equity |
Loading...
